Glenn Bedsole, MD
Infectious Disease · Montgomery, ALNPI 1699755975
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.1% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $518 and has fallen 73.8% since, to $136 in 2025. That places this record below the midpoint for infectious disease clinicians in AL, where the typical reported total is $923.
Across 75 payments — averaging $16.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$277
- Organogenesis Inc.$276
- Osiris Therapeutics Inc.$118
- Integra Lifesciences Corporation$111
- AbbVie$89
- Kerecis Limited$86
- plus $293 from 8 others
What the payments were for
- Speaking & faculty fees$867%
- Food & beverage$1,16493%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 15 | $277 |
| Organogenesis Inc. | 10 | $276 |
| Osiris Therapeutics Inc. | 1 | $118 |
| Integra Lifesciences Corporation | 27 | $111 |
| AbbVie(2 entities) | 5 | $89 |
| Kerecis Limited | 4 | $86 |
| Convatec Inc. | 3 | $59 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $57 |
| Solventum Corporation | 2 | $48 |
| Triad Life Sciences Inc. | 1 | $43 |
| Aroa Biosurgery Incorporated | 1 | $24 |
| KCI USA, Inc. | 1 | $22 |
| Urgo Medical North America, LLC | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,250 in reported general payments places this provider in the 50th percentile of 104 infectious disease providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin Sulfate | 12 | $21,383 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Montgomery
- Carlos Reyes-SacinMontgomery$97K
- April TruettMontgomery$85K
- Mladen SokanovicMontgomery$1K
- Ali HassounHuntsville$262K
- John BaddleyBirmingham$113K
- Christina MuznyBirmingham$111K
- Sonya HeathBirmingham$80K
- William GeislerBirmingham$63K
- Edward HookBirmingham$61K
- Edgar OvertonBirmingham$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.